Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Fadeenko G"'
Autor:
Caldas M., Perez-Aisa A., Tepes B., Keco-Huerga A., Bujanda L., Lucendo A. J., Rodrigo L., Vaira D., Fernandez-Salazar L., Huguet J. M., Perez-Lasala J., Jurecic N. B., Fadeenko G., Barrio J., Areia M., Ortuno J., Pellicano R., Leja M., Molina-Infante J., Bogomolov P., Alekseenko S., Dominguez-Cajal M., Gomez-Camarero J., Ntouli V., Martinez-Dominguez S. J., Ruiz-Zorrilla R., Nunez O., Silkanovna Sarsenbaeva A., Almela P., Phull P., Espada M., Puig I., Nyssen O. P., Megraud F., O'Morain C., Gisbert J. P., the HP-EuReg Investigators, Gravina AG, Romano M.
Publikováno v:
ANTIBIOTICS-BASEL
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Antibiotics
Volume 10
Issue 8
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Antibiotics, Vol 10, Iss 965, p 965 (2021)
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Antibiotics
Volume 10
Issue 8
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Antibiotics, Vol 10, Iss 965, p 965 (2021)
Statins could increase the effectiveness of Helicobacter pylori eradication therapies due to their anti-inflammatory effect. The aim of this study was to analyze the impact of this therapeutic association in real life. This is a multicenter, prospect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a80daa378b7f1d1cb1b693e0224a76a6
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=14972
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=14972
Autor:
Nyssen OP, Bordin D, Tepes B, Pérez-Aisa Á, Vaira D, Caldas M, Bujanda L, Castro-Fernandez M, Lerang F, Leja M, Rodrigo L, Rokkas T, Kupcinskas L, Pérez- Lasala J, Jonaitis L, Shvets O, Gasbarrini A, Simsek H, Axon ATR, Buzás G, Machado JC, Niv Y, Boyanova L, Goldis A, Lamy V, Tonkic A, Przytulski K, Beglinger C, Venerito M, Bytzer P, Capelle L, Milosavljević T, Milivojevic V, Veijola L, Molina-Infante J, Vologzhanina L, Fadeenko G, Ariño I, Fiorini G, Garre A, Garrido J, F Pérez C, Puig I, Heluwaert F, Megraud F, O'Morain C, Gisbert JP, Romano M
Publikováno v:
Gut
Gut, 2020, pp.gutjnl-2020-321372. ⟨10.1136/gutjnl-2020-321372⟩
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Consejo Superior de Investigaciones Científicas (CSIC)
Gut, BMJ Publishing Group, 2020, pp.gutjnl-2020-321372. ⟨10.1136/gutjnl-2020-321372⟩
Gut, 2020, pp.gutjnl-2020-321372. ⟨10.1136/gutjnl-2020-321372⟩
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Consejo Superior de Investigaciones Científicas (CSIC)
Gut, BMJ Publishing Group, 2020, pp.gutjnl-2020-321372. ⟨10.1136/gutjnl-2020-321372⟩
ObjectiveThe best approach for Helicobacter pylori management remains unclear. An audit process is essential to ensure clinical practice is aligned with best standards of care.DesignInternational multicentre prospective non-interventional registry st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95329bb53a89c7ff72ca12afbb081904
https://www.hal.inserm.fr/inserm-02996928
https://www.hal.inserm.fr/inserm-02996928
Introduction: Antibiotic resistance is the main factor influencing the ef-ficacy of treatments to eradicate the infection by Helicobacter pylori (H. pylori). The treatments including clarithromycin are the most frequently used in first-line ; however
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::2e28eb5311beaa4713d5e4615a5e3a53
https://www.bib.irb.hr/1245995
https://www.bib.irb.hr/1245995
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Introduction: Antibiotic resistance is the major factor affecting our ability to cure Helicobacter pylori infection. Quadruple therapy is currently recommended ; however, triple therapy with two antibiotics may be sufficient in those patients without
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::84c08839f679e39b00d8bf677a1ff70e
https://www.bib.irb.hr/1246078
https://www.bib.irb.hr/1246078
Introduction: Antibiotic resistance is the major factor affecting our ability to cure Helicobacter pylori infection. Understanding the different H. pylori antibiotic resistances could be the key to improve treatment effectiveness. Aims & Methods: To
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::f51a610372d49103d544e5ff8529c4a2
https://www.bib.irb.hr/1246095
https://www.bib.irb.hr/1246095
Introduction: Bacterial antibiotic resistance changes over time based on multiple factors. It is essential to study these trends to apply preventive strategies to help reducing such resistances.Aims & Methods: To conduct a time-trend analysis of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::d14c948e36edcdf74631d1692437eab7
https://www.bib.irb.hr/1246071
https://www.bib.irb.hr/1246071
Introduction: The best approach for Helicobacter pylori management remains unclear. An audit process is essential to ensure clinical practice is aligned with best standards of care.Aims & Methods: International multicentre prospective non-interventio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::2f2eeeb7abee168e35bb265acb14332f
https://www.bib.irb.hr/1246069
https://www.bib.irb.hr/1246069
Publikováno v:
Современная гастроэнтерология; № 3 (2019); 58-65
Сучасна гастроентерологія; № 3 (2019); 58-65
Modern Gastroenterology; № 3 (2019); 58-65
Сучасна гастроентерологія; № 3 (2019); 58-65
Modern Gastroenterology; № 3 (2019); 58-65
Non-alcoholic fatty liver disease (NAFLD) is a disease characterized by liver steatosis and the ability to progress to more serious pathological conditions, including non-alcoholic steatohepatitis (NASH), fibrosis and cirrhosis of the liver. The prog
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.